© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
Author | Giovanni Scambia, MD
Articles
COUNTERPOINT: Primary Debulking Surgery vs Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer
June 15, 2017
In a Significant Percentage of Patients, Neoadjuvant Therapy Yields Equivalent Survival, With Better Quality of Life and Lower Costs